Related Experiment Video
Updated: Jun 2, 2026
Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
Molecular characteristics of pancreatic ductal adenocarcinoma
Niki A Ottenhof1, Roeland F de Wilde, Anirban Maitra
1Department of Pathology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Abstract:
Pancreatic cancer is an almost universally lethal disease and despite extensive research over the last decades, this has not changed significantly. Nevertheless, much progress has been made in understanding the pathogenesis of pancreatic ductal adenocarcinoma (PDAC) suggesting that different therapeutic strategies based on these new insights are forthcoming. Increasing focus exists on designing the so-called targeted treatment strategies in which the genetic characteristics of a tumor guide therapy. In the past, the focus of research was on identifying the most frequently affected genes in PDAC, but with the complete sequencing of the pancreatic cancer genome the focus has shifted to defining the biological function that the altered genes play. In this paper we aimed to put the genetic alterations present in pancreatic cancer in the context of their role in signaling pathways. In addition, this paper provides an update of the recent advances made in the development of the targeted treatment approach in PDAC.
Insights
Pancreatic cancer remains lethal, but understanding its genetic pathways is paving the way for targeted treatments. Research now focuses on the biological function of altered genes in pancreatic ductal adenocarcinoma (PDAC) for new therapies.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Pancreatic cancer, particularly pancreatic ductal adenocarcinoma (PDAC), has a poor prognosis despite extensive research.
- Recent advances in understanding PDAC pathogenesis offer hope for novel therapeutic strategies.
Purpose of the Study:
- To contextualize genetic alterations in pancreatic cancer within their roles in signaling pathways.
- To provide an update on targeted treatment approaches for PDAC based on genetic insights.
Main Methods:
- Review of current literature on pancreatic cancer genomics and signaling pathways.
- Analysis of genetic alterations and their functional impact in PDAC.
Main Results:
- The focus in PDAC research has shifted from identifying frequently altered genes to understanding the biological function of these alterations.
- Genetic alterations in PDAC play critical roles in various signaling pathways.
Conclusions:
- Understanding the functional role of genetic alterations in signaling pathways is crucial for developing effective targeted therapies for PDAC.
- Advances in genomic sequencing are driving the development of personalized treatment strategies for pancreatic cancer.
Related Concept Videos
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:35Cancer Cell Migration through Invadopodia
01:19Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...